Recent Advances in the Genetics of Autism Spectrum Disorder

Current Neurology and Neuroscience Reports

Volumn 15, Issue 6, 2015, Pages

  De Rubeis, Silvia ^a   Buxbaum, Joseph D ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Autism risk genes; Autism spectrum disorder; Copy number variation; De novo variation; Exome sequencing; Heritability

Indexed keywords

N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; SODIUM CHANNEL NAV1.2;

ANK2 GENE; AUTISM; CHD8 GENE; COPY NUMBER VARIATION; CUL3 GENE; DYRK1A GENE; GENDER BIAS; GENE; GENE FREQUENCY; GENE IDENTIFICATION; GENE MAPPING; GENE MUTATION; GENETIC ASSOCIATION; GENETIC CORRELATION; GENETIC DIFFERENCE; GENETIC RISK; GENETIC VARIABILITY; GRIN2B GENE; HEREDITY; HERITABILITY; HUMAN; KATNAL2 GENE; NEUROPATHOLOGY; NEXT GENERATION SEQUENCING; NONHUMAN; PATHOPHYSIOLOGY; POGZ GENE; REVIEW; RISK ASSESSMENT; SCN2A GENE; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; TBR1 GENE; ANIMAL; EXOME; GENETIC PREDISPOSITION; GENETICS; HUMAN GENOME; RISK FACTOR;

ANIMALS; AUTISM SPECTRUM DISORDER; DNA COPY NUMBER VARIATIONS; EXOME; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; HUMANS; RISK FACTORS;

EID: 84928978805     PISSN: 15284042     EISSN: 15346293     Source Type: Journal    
DOI: 10.1007/s11910-015-0553-1     Document Type: Review

References (83)

1. Levy SE, Mandell DS, Schultz RT. Autism. Lancet. 2009;374:1627–38.
2. Jacquemont S, Coe BP, Hersch M, Duyzend MH, Krumm N, Bergmann S, et al. A higher mutational burden in females supports a “female protective model” in neurodevelopmental disorders. Am J Human Gene. 2014;94:415–25. This study analyzed the genetic variation in a cohort of 15,585 individuals with neurodevelopmental disorders to understand whether gender bias might be due to a higher mutational burden in females.
3. Kohane IS, McMurry A, Weber G, MacFadden D, Rappaport L, Kunkel L, et al. The co-morbidity burden of children and young adults with autism spectrum disorders. PLoS One. 2012;7:e33224.
4. Betancur C. Etiological heterogeneity in autism spectrum disorders: more than 100 genetic and genomic disorders and still counting. Brain Res. 2011;1380:42–77.
5. Visscher PM, Hill WG, Wray NR. Heritability in the genomics era—concepts and misconceptions. Nat Rev Genet. 2008;9:255–66.
6. Boomsma D, Busjahn A, Peltonen L. Classical twin studies and beyond. Nat Rev Genet. 2002;3:872–82.
7. Bailey A, Le Couteur A, Gottesman I, Bolton P, Simonoff E, Yuzda E, et al. Autism as a strongly genetic disorder: evidence from a British twin study. Psychol Med. 1995;25:63–77.
8. Ritvo ER, Freeman BJ, Mason-Brothers A, Mo A, Ritvo AM. Concordance for the syndrome of autism in 40 pairs of afflicted twins. Am J Psychiatry. 1985;142:74–7.
9. Steffenburg S, Gillberg C, Hellgren L, Andersson L, Gillberg IC, Jakobsson G, et al. A twin study of autism in Denmark, Finland, Iceland, Norway and Sweden. J Child Psychol Psychiatry. 1989;30:405–16.
10. Folstein S, Rutter M. Infantile autism: a genetic study of 21 twin pairs. J Child Psychol Psychiatry. 1977;18:297–321.
11. Gaugler T, Klei L, Sanders SJ, Bodea CA, Goldberg AP, Lee AB, et al. Most genetic risk for autism resides with common variation. Nat Gene. 2014;46:881–5. This study used an epidemiologically ascertained population from Sweden to assess the contribution of rare and common variation to narrow-sense heritability. The study authors estimated that half of the variance in liability is due to common variants.
12. Hallmayer J, Cleveland S, Torres A, Phillips J, Cohen B, Torigoe T et al. Genetic heritability and shared environmental factors among twin pairs with autism. Arch Gene Psychiatry. 2011.
13. Sandin S, Lichtenstein P, Kuja-Halkola R, Larsson H, Hultman CM, Reichenberg A. The familial risk of autism. JAMA. 2014;311:1770–7. This is the largest population-based study on autism heritiability to date, with 2.5 million Swedish families including twins, full siblings and half siblings. The study has calculated the relative recurrence risk for relatives of ASD probands and provided an estimate of ASD heritability.
14. Klei L, Sanders SJ, Murtha MT, Hus V, Lowe JK, Willsey AJ, et al. Common genetic variants, acting additively, are a major source of risk for autism. Mole Autism. 2012;3:9. This study was the first to make use of SNP data to estimate narrow-sense heritability in ASD using simplex and multiplex families and demonstrated the significant contribution of polygenic SNP load in ASD risk architecture.
15. Gronborg TK, Schendel DE, Parner ET. Recurrence of autism spectrum disorders in full- and half-siblings and trends over time: a population-based cohort study. JAMA Pediatrics. 2013;167:947–53.
16. Frazer KA, Murray SS, Schork NJ, Topol EJ. Human genetic variation and its contribution to complex traits. Nat Rev Genet. 2009;10:241–51.
17. Wang K, Zhang H, Ma D, Bucan M, Glessner JT, Abrahams BS, et al. Common genetic variants on 5p14.1 associate with autism spectrum disorders. Nature. 2009;459:528–33.
18. Weiss LA, Arking DE, Daly MJ, Chakravarti A. A genome-wide linkage and association scan reveals novel loci for autism. Nature. 2009;461:802–8.
19. Anney R, Klei L, Pinto D, Regan R, Conroy J, Magalhaes TR, et al. A genome-wide scan for common alleles affecting risk for autism. Hum Mol Genet. 2010;19:4072–82.
20. Devlin B, Melhem N, Roeder K. Do common variants play a role in risk for autism? Evidence and theoretical musings. Brain Res. 2011;1380:78–84.
21. Anney R, Klei L, Pinto D, Almeida J, Bacchelli E, Baird G, et al. Individual common variants exert weak effects on the risk for autism spectrum disorderspi. Hum Mol Genet. 2012;21:4781–92.
22. Devlin B, Scherer SW. Genetic architecture in autism spectrum disorder. Curr Opin Gene Dev. 2012;22:229–37.
23. Depienne C, Moreno-De-Luca D, Heron D, Bouteiller D, Gennetier A, Delorme R, et al. Screening for genomic rearrangements and methylation abnormalities of the 15q11-q13 region in autism spectrum disorders. Biol Psychiatry. 2009;66:349–59.
24. Pinto D, Delaby E, Merico D, Barbosa M, Merikangas A, Klei L, et al. Convergence of genes and cellular pathways dysregulated in autism spectrum disorders. Am J Human Gene. 2014;94:677–94. This study analyzed the burden of copy number variation in 2,446 ASD-affected families from the Autism Genome Project. The study confirmed an excess of deletions and duplications in affected versus control groups and highlighted the large heterogeneity of pathogenic CNVs.
25. Sebat J, Lakshmi B, Malhotra D, Troge J, Lese-Martin C, Walsh T, et al. Strong association of de novo copy number mutations with autism. Science. 2007;316:445–9.
26. Sanders SJ, Ercan-Sencicek AG, Hus V, Luo R, Murtha MT, Moreno-De-Luca D, et al. Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autism. Neuron. 2011;70:863–85.
27. Levy D, Ronemus M, Yamrom B, Lee YH, Leotta A, Kendall J, et al. Rare de novo and transmitted copy-number variation in autistic spectrum disorders. Neuron. 2011;70:886–97.
28. Marshall CR, Noor A, Vincent JB, Lionel AC, Feuk L, Skaug J, et al. Structural variation of chromosomes in autism spectrum disorder. Am J Hum Genet. 2008;82:477–88.
29. Pinto D, Pagnamenta AT, Klei L, Anney R, Merico D, Regan R, et al. Functional impact of global rare copy number variation in autism spectrum disorders. Nature. 2010;466:368–72.
30. Glessner JT, Wang K, Cai G, Korvatska O, Kim CE, Wood S, et al. Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature. 2009;459:569–73.
31. Poultney CS, Goldberg AP, Drapeau E, Kou Y, Harony-Nicolas H, Kajiwara Y, et al. Identification of small exonic CNV from whole-exome sequence data and application to autism spectrum disorder. Am J Human Gene. 2013;93:607–19. One of two first studies detecting small deletions and duplucations in subjects with ASD using whole-exome sequencing data. By detecting and analyzing such variation in a case-control sample, the study showed a burden for small deletions and duplications, which could not be detected by earlier microarray studies.
32. Krumm N, O'Roak BJ, Karakoc E, Mohajeri K, Nelson B, Vives L, et al. Transmission disequilibrium of small CNVs in simplex autism. Am J Human Gene. 2013;93:595–606. One of two first studies detecting small deletions and duplications in subjects with ASD using whole-exome sequencing data. By detecting and analyzing such variation in 411 ASD families, this study showed a burden for small deletions and duplications, which could not be detected by earlier microarray studies.
33. Fromer M, Moran JL, Chambert K, Banks E, Bergen SE, Ruderfer DM, et al. Discovery and statistical genotyping of copy-number variation from whole-exome sequencing depth. Am J Hum Genet. 2012;91:597–607.
34. Chahrour M, Zoghbi HY. The story of Rett syndrome: from clinic to neurobiology. Neuron. 2007;56:422–37.
35. De Rubeis S, He X, Goldberg AP, Poultney CS, Samocha K, Ercument Cicek A et al. Synaptic, transcriptional and chromatin genes disrupted in autism. Nature. 2014. One of two recent large whole-exome sequencing studies for ASD. By sequencing 3,871 ASD cases and 9,937 ancestry-matched or parental controls from the Autism Sequencing Consortium, the study identified 33 risk genes with a false-discovery rate of <0.1 and implicated synaptic networks, transcriptional regulation and chromatin remodeling in ASD pathophysiology.
36. Neale BM, Kou Y, Liu L, Ma'ayan A, Samocha KE, Sabo A, et al. Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature. 2012;485:242–5. One of the initial four whole-exome sequencing studies in ASD. The four studies collectively sequenced ∼1000 trios, showed the contribution of de novo SNVs and indels in ASD risk architecture, and uncovered 9 ASD risk genes.
37. Sanders SJ, Murtha MT, Gupta AR, Murdoch JD, Raubeson MJ, Willsey AJ, et al. De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature. 2012;485:237–41. One of the initial four whole-exome sequencing studies in ASD. The four studies collectively sequenced ∼1000 trios, showed the contribution of de novo SNVs and indels in ASD risk architecture, and uncovered 9 ASD risk genes.
38. O'Roak BJ, Vives L, Girirajan S, Karakoc E, Krumm N, Coe BP, et al. Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature. 2012;485:246–50. One of the initial four whole-exome sequencing studies in ASD. The four studies collectively sequenced ∼1000 trios, showed the contribution of de novo SNVs and indels in ASD risk architecture, and uncovered 9 ASD risk genes.
39. Iossifov I, Ronemus M, Levy D, Wang Z, Hakker I, Rosenbaum J, et al. De novo gene disruptions in children on the autistic spectrum. Neuron. 2012;74:285–99. One of the initial four whole-exome sequencing studies in ASD. The four studies collectively sequenced ∼1000 trios, showed the contribution of de novo SNVs and indels in ASD risk architecture, and uncovered 9 ASD risk genes.
40. Iossifov I, O'Roak BJ, Sanders SJ, Ronemus M, Krumm N, Levy D, et al. The contribution of de novo coding mutations to autism spectrum disorder. Nature. 2014;515:216–21. One of two recent large whole-exome sequencing studies for ASD. By sequencing approximately 2,500 families from the Simons Simplex Collection, the study identified 27 ASD genes with recurrent de novo loss-of-function mutations.
41. Lim ET, Raychaudhuri S, Sanders SJ, Stevens C, Sabo A, MacArthur DG, et al. Rare complete knockouts in humans: population distribution and significant role in autism spectrum disorders. Neuron. 2013;77:235–42. One of two whole-exome sequencing studies showing the role of inherited variation in ASD risk architecture. Using a case-control sample, this study showed a significant contribution of autosomal recessive and X-linked variation in ASD liability.
42. Yu TW, Chahrour MH, Coulter ME, Jiralerspong S, Okamura-Ikeda K, Ataman B, et al. Using whole-exome sequencing to identify inherited causes of autism. Neuron. 2013;77:259–73. One of two whole-exome sequencing studies showing the role of inherited variation in ASD risk architecture. By analyzing genetic variation in consanguineous families, this study highlighted hypomorphic and other alleles in recessive genes in familial ASD.
43. MacArthur DG, Balasubramanian S, Frankish A, Huang N, Morris J, Walter K, et al. A systematic survey of loss-of-function variants in human protein-coding genes. Science. 2012;335:823–8.
44. Chahrour MH, Yu TW, Lim ET, Ataman B, Coulter ME, Hill RS, et al. Whole-exome sequencing and homozygosity analysis implicate depolarization-regulated neuronal genes in autism. PLoS Genet. 2012;8, e1002635.
45. Casey JP, Magalhaes T, Conroy JM, Regan R, Shah N, Anney R, et al. A novel approach of homozygous haplotype sharing identifies candidate genes in autism spectrum disorder. Hum Genet. 2012;131:565–79.
46. Veltman JA, Brunner HG. De novo mutations in human genetic disease. Nat Rev Genet. 2012;13:565–75.
47. Conrad DF, Keebler JE, DePristo MA, Lindsay SJ, Zhang Y, Casals F, et al. Variation in genome-wide mutation rates within and between human families. Nat Genet. 2011;43:712–4.
48. Roach JC, Glusman G, Smit AF, Huff CD, Hubley R, Shannon PT, et al. Analysis of genetic inheritance in a family quartet by whole-genome sequencing. Science. 2010;328:636–9.
49. Kong A, Frigge ML, Masson G, Besenbacher S, Sulem P, Magnusson G, et al. Rate of de novo mutations and the importance of father’s age to disease risk. Nature. 2012;488:471–5.
50. Michaelson JJ, Shi Y, Gujral M, Zheng H, Malhotra D, Jin X, et al. Whole-genome sequencing in autism identifies hot spots for de novo germline mutation. Cell. 2012;151:1431–42.
51. Kirov G, Pocklington AJ, Holmans P, Ivanov D, Ikeda M, Ruderfer D, et al. De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia. Mol Psychiatry. 2012;17:142–53.
52. Soemedi R, Wilson IJ, Bentham J, Darlay R, Topf A, Zelenika D, et al. Contribution of global rare copy-number variants to the risk of sporadic congenital heart disease. Am J Hum Genet. 2012;91:489–501.
53. Hehir-Kwa JY, Rodriguez-Santiago B, Vissers LE, de Leeuw N, Pfundt R, Buitelaar JK, et al. De novo copy number variants associated with intellectual disability have a paternal origin and age bias. J Med Genet. 2011;48:776–8.
54. Dong S, Walker MF, Carriero NJ, DiCola M, Willsey AJ, Ye AY, et al. De novo insertions and deletions of predominantly paternal origin are associated with autism spectrum disorder. Cell Reports. 2014;9:16–23. This study applied robust approaches for the identification of indels from whole-exome sequencing data in 787 ASD families from the Simons Simplex Collection, and extended the contribution of indels in ASD liability.
55. McGrath JJ, Petersen L, Agerbo E, Mors O, Mortensen PB, Pedersen CB. A comprehensive assessment of parental age and psychiatric disorders. JAMA Psychiatry. 2014;71:301–9.
56. Frans EM, Sandin S, Reichenberg A, Langstrom N, Lichtenstein P, McGrath JJ, et al. Autism risk across generations: a population-based study of advancing grandpaternal and paternal age. JAMA Psychiatry. 2013;70:516–21.
57. Hultman CM, Sandin S, Levine SZ, Lichtenstein P, Reichenberg A. Advancing paternal age and risk of autism: new evidence from a population-based study and a meta-analysis of epidemiological studies. Mol Psychiatry. 2011;16:1203–12.
58. Fombonne E. Epidemiology of autistic disorder and other pervasive developmental disorders. J Clin Psychiatry. 2005;66 Suppl 10:3–8.
59. Baron-Cohen S, Lombardo MV, Auyeung B, Ashwin E, Chakrabarti B, Knickmeyer R. Why are autism spectrum conditions more prevalent in males? PLoS Biol. 2011;9:e1001081.
60. Bagni C, Tassone F, Neri G, Hagerman R. Fragile X syndrome: causes, diagnosis, mechanisms, and therapeutics. J Clin Invest. 2012;122:4314–22.
61. Tropeano M, Ahn JW, Dobson RJ, Breen G, Rucker J, Dixit A, et al. Male-biased autosomal effect of 16p13.11 copy number variation in neurodevelopmental disorders. PLoS One. 2013;8:e61365.
62. Sato D, Lionel AC, Leblond CS, Prasad A, Pinto D, Walker S, et al. SHANK1 deletions in males with autism spectrum disorder. Am J Hum Genet. 2012;90:879–87.
63. Girirajan S, Rosenfeld JA, Coe BP, Parikh S, Friedman N, Goldstein A, et al. Phenotypic heterogeneity of genomic disorders and rare copy-number variants. N Engl J Med. 2012;367:1321–31.
64. Robinson EB, Lichtenstein P, Anckarsater H, Happe F, Ronald A. Examining and interpreting the female protective effect against autistic behavior. Proc Natl Acad Sci U S A. 2013;110:5258–62. This study has assessed quantitative ASD traits in females and males of two large populations of monozygotic and dizygotic twins and has provided support for the female protective effect theory.
65. He X, Sanders SJ, Liu L, De Rubeis S, Lim ET, Sutcliffe JS, et al. Integrated model of de novo and inherited genetic variants yields greater power to identify risk genes. PLoS Gene. 2013;9:e1003671. This paper describes an innovative statistical method to assess disease association of genes by integrating information on de novo and inherited variation, as well as variation identified in case-control samples.
66. Buxbaum JD, Daly MJ, Devlin B, Lehner T, Roeder K, State MW. The autism sequencing consortium: large-scale, high-throughput sequencing in autism spectrum disorders. Neuron. 2012;76:1052–6.
67. Fischbach GD, Lord C. The Simons Simplex Collection: a resource for identification of autism genetic risk factors. Neuron. 2010;68:192–5.
68. Zoghbi HY. Postnatal neurodevelopmental disorders: meeting at the synapse? Science. 2003;302:826–30.
69. Fromer M, Pocklington AJ, Kavanagh DH, Williams HJ, Dwyer S, Gormley P, et al. De novo mutations in schizophrenia implicate synaptic networks. Nature. 2014;506:179–84. This is the largest whole-exome sequencing of de novo mutations on schizophrenia to date, with over 600 trios sequenced.
70. Verpelli C, Sala C. Molecular and synaptic defects in intellectual disability syndromes. Curr Opin Neurobiol. 2012;22:530–6.
71. Delorme R, Ey E, Toro R, Leboyer M, Gillberg C, Bourgeron T. Progress toward treatments for synaptic defects in autism. Nat Med. 2013;19:685–94.
72. Kang HJ, Kawasawa YI, Cheng F, Zhu Y, Xu X, Li M, et al. Spatio-temporal transcriptome of the human brain. Nature. 2011;478:483–9.
73. Miller JA, Ding SL, Sunkin SM, Smith KA, Ng L, Szafer A, et al. Transcriptional landscape of the prenatal human brain. Nature. 2014;508:199–206.
74. Parikshak NN, Luo R, Zhang A, Won H, Lowe JK, Chandran V, et al. Integrative functional genomic analyses implicate specific molecular pathways and circuits in autism. Cell. 2013;155:1008–21. This is one of the recent studies that have leveraged the BrainSpan transcriptome dataset of multiple human brain regions across develoment. This study has used a top-down weighted gene co-expression network approach integrating a broad set of genes associated with ASD and intellectual disability.
75. Willsey AJ, Sanders SJ, Li M, Dong S, Tebbenkamp AT, Muhle RA, et al. Coexpression networks implicate human midfetal deep cortical projection neurons in the pathogenesis of autism. Cell. 2013;155:997–1007. This is one of the recent studies that have leveraged the BrainSpan transcriptome dataset of multiple human brain regions across develoment. This study has used a bottom-up co-expression network approach incorporating high confidence ASD risk genes identified by the large-scale sequencing studies on ASD families.
76. Xu X, Wells AB, O'Brien DR, Nehorai A, Dougherty JD. Cell type-specific expression analysis to identify putative cellular mechanisms for neurogenetic disorders. J Neurosci. 2014;34:1420–31.
77. Uddin M, Tammimies K, Pellecchia G, Alipanahi B, Hu P, Wang Z, et al. Brain-expressed exons under purifying selection are enriched for de novo mutations in autism spectrum disorder. Nat Genet. 2014;46:742–7.
78. Bernier R, Golzio C, Xiong B, Stessman HA, Coe BP, Penn O, et al. Disruptive CHD8 mutations define a subtype of autism early in development. Cell. 2014;158:263–76. This study is a first phenotypic characterization of 15 subjects carrying mutations in the newly discovered ASD risk gene CHD8.
79. Sugathan A, Biagioli M, Golzio C, Erdin S, Blumenthal I, Manavalan P, et al. CHD8 regulates neurodevelopmental pathways associated with autism spectrum disorder in neural progenitors. Proc Natl Acad Sci U S A. 2014;111:E4468–4477.
80. Chaste P, Klei L, Sanders SJ, Murtha MT, Hus V, Lowe JK, et al. Adjusting head circumference for covariates in autism: clinical correlates of a highly heritable continuous trait. Biol Psychiatry. 2013;74:576–84.
81. Deriziotis P, O'Roak BJ, Graham SA, Estruch SB, Dimitropoulou D, Bernier RA, et al. De novo TBR1 mutations in sporadic autism disrupt protein functions. Nat Commun. 2014;5:4954.
82. Chang KJ, Zollinger DR, Susuki K, Sherman DL, Makara MA, Brophy PJ, et al. Glial ankyrins facilitate paranodal axoglial junction assembly. Nat Neurosci. 2014;17:1673–81.
83. Huang TN, Chuang HC, Chou WH, Chen CY, Wang HF, Chou SJ, et al. Tbr1 haploinsufficiency impairs amygdalar axonal projections and results in cognitive abnormality. Nat Neurosci. 2014;17:240–7. This study is a first report on the neuroanatomical and behavioral characterization of a mouse model for the haploinsufficiency of the newly discovered ASD risk gene TBR1.